Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | NA0587 | — |
Mild injection site pain; This is a spontaneous report received from a Physician. A 41-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 14Oct2025 as dose 1, single (Lot number: NA0587) at the age of 41 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEVOTHYROXINE; ORAL CONTRACEPTIVE NOS. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 14Oct2025, outcome "recovering", described as "Mild injection site pain". Therapeutic measures were not taken as a result of vaccination site pain. No follow-up attempts are possible.
LEVOTHYROXINE; ORAL CONTRACEPTIVE NOS